Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4ABBVIE

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

MILNACIPRAN HYDROCHLORIDE

US Patent Number : 7994220

Drug Substance Claim :

Drug Product Claim :

Application Number : 22256

Patent Use Code : U-819

Delist Requested :

Patent Use Description : MANAGEMENT OF FIBROMYA...

Patent Expiration Date : 2029-09-19

Abbvie Company Banner

02

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

MILNACIPRAN HYDROCHLORIDE

US Patent Number : 7994220

Drug Substance Claim :

Drug Product Claim :

Application Number : 22256

Patent Use Code : U-819

Delist Requested :

Patent Use Description : MANAGEMENT OF FIBROMYA...

Patent Expiration Date : 2029-09-19

Abbvie Company Banner

03

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

MILNACIPRAN HYDROCHLORIDE

US Patent Number : 7994220

Drug Substance Claim :

Drug Product Claim :

Application Number : 22256

Patent Use Code : U-819

Delist Requested :

Patent Use Description : MANAGEMENT OF FIBROMYA...

Patent Expiration Date : 2029-09-19

Abbvie Company Banner

04

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

MILNACIPRAN HYDROCHLORIDE

US Patent Number : 7994220

Drug Substance Claim :

Drug Product Claim :

Application Number : 22256

Patent Use Code : U-819

Delist Requested :

Patent Use Description : MANAGEMENT OF FIBROMYA...

Patent Expiration Date : 2029-09-19

Abbvie Company Banner